Dihlmann S - Search Results

1

Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics.

Dihlmann S, von Knebel Doeberitz M. Dihlmann S, et al. Int J Cancer. 2005 Feb 10;113(4):515-24. doi: 10.1002/ijc.20609. Int J Cancer. 2005. PMID: 15472907 Review.

2

Inhibitory mechanisms of two Uncaria tomentosa extracts affecting the Wnt-signaling pathway.

Gurrola-Díaz CM, García-López PM, Gulewicz K, Pilarski R, Dihlmann S. Gurrola-Díaz CM, et al. Among authors: dihlmann s. Phytomedicine. 2011 Jun 15;18(8-9):683-90. doi: 10.1016/j.phymed.2010.11.002. Epub 2010 Dec 14. Phytomedicine. 2011. PMID: 21156346

3

Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.

Dihlmann S, Tao S, Echterdiek F, Herpel E, Jansen L, Chang-Claude J, Brenner H, Hoffmeister M, Kloor M. Dihlmann S, et al. Int J Cancer. 2014 Nov 15;135(10):2387-96. doi: 10.1002/ijc.28891. Epub 2014 Apr 28. Int J Cancer. 2014. PMID: 24729378

4

Restoration of absent in melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cells.

Patsos G, Germann A, Gebert J, Dihlmann S. Patsos G, et al. Among authors: dihlmann s. Int J Cancer. 2010 Apr 15;126(8):1838-1849. doi: 10.1002/ijc.24905. Int J Cancer. 2010. PMID: 19795419

5

Transcriptional activation of the beta-catenin gene at the invasion front of colorectal liver metastases.

Bandapalli OR, Dihlmann S, Helwa R, Macher-Goeppinger S, Weitz J, Schirmacher P, Brand K. Bandapalli OR, et al. Among authors: dihlmann s. J Pathol. 2009 Jul;218(3):370-9. doi: 10.1002/path.2539. J Pathol. 2009. PMID: 19347947

6

The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.

Woerner SM, Kloor M, Schwitalle Y, Youmans H, Doeberitz Mv, Gebert J, Dihlmann S. Woerner SM, et al. Among authors: dihlmann s. Genes Chromosomes Cancer. 2007 Dec;46(12):1080-9. doi: 10.1002/gcc.20493. Genes Chromosomes Cancer. 2007. PMID: 17726700

7

Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.

Dihlmann S, Kloor M, Fallsehr C, von Knebel Doeberitz M. Dihlmann S, et al. Carcinogenesis. 2005 Sep;26(9):1503-12. doi: 10.1093/carcin/bgi120. Epub 2005 May 11. Carcinogenesis. 2005. PMID: 15888491

8

Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin.

Dihlmann S, Klein S, Doeberitz Mv Mv. Dihlmann S, et al. Mol Cancer Ther. 2003 Jun;2(6):509-16. Mol Cancer Ther. 2003. PMID: 12813129

9

Prevention of chemotherapy-related toxic side effects by infection with adeno-associated virus type 2.

Eisold S, Dihlmann S, Linnebacher M, Ryschich E, Aulmann M, Schmidt J, Schlehofer JR, Ridder R, von Knebel Doeberitz M. Eisold S, et al. Among authors: dihlmann s. Int J Cancer. 2002 Aug 10;100(5):606-14. doi: 10.1002/ijc.10152. Int J Cancer. 2002. PMID: 12124812

10

Expression profiling of CC531 colon carcinoma cells reveals similar regulation of beta-catenin target genes by both butyrate and aspirin.

Germann A, Dihlmann S, Hergenhahn M, Doeberitz Mv, Koesters R. Germann A, et al. Among authors: dihlmann s. Int J Cancer. 2003 Aug 20;106(2):187-97. doi: 10.1002/ijc.11215. Int J Cancer. 2003. PMID: 12800193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results